Active endogenous metabolites regulate the viability of cells. This process is controlled by a series ofinteractions between small metabolites and large proteins. Previously, several studies had reported thatmetabolit...Active endogenous metabolites regulate the viability of cells. This process is controlled by a series ofinteractions between small metabolites and large proteins. Previously, several studies had reported thatmetabolite regulates the protein functions, such as diacylglycerol to protein kinase C, lactose regulationof the lac repressor, and HIF-1α stabilization by 2-hydroxyglutarate. However, decades old traditionalbiochemical methods are insufficient to systematically investigate the bio-molecular reactions for a high-throughput discovery. Here, we have reviewed an update on the recently developed chemical proteomicscalled activity-based protein profiling （ABPP）. ABPP is able to identify proteins interacted eithercovalently or non-covalently with metabolites significantly. Thus, ABPP will facilitate the characteriza-tion of specific metabolite regulating; proteins in human disease progression.展开更多
Protein-metabolite interactions(PMIs)play important roles in various biological processes,especially in disease progression.However,due to the complexity of living cells,it is very difficult to identify specific PMIs....Protein-metabolite interactions(PMIs)play important roles in various biological processes,especially in disease progression.However,due to the complexity of living cells,it is very difficult to identify specific PMIs.Herein,we chose one oncogenic factor,metadherin(MTDH),as a bait to identify its in vivo interacting metabolites in cancer cells.Cholesterol is an important metabolite and essential structural component of cell membranes.It could also drive several diseases including cancer.Interestingly,we found that cholesterol robustly interacted with MTDH and downregulated the expression of MTDH in cancer cells.Furthermore,MTDH disturbed metabolite alterations under cholesterol treatment in MTDH transduced cancer cells.Collectively,our results uncover an undescribed PMI where MTDH,as an oncogenic factor,might positively regulate cancer progression by interacting with choleste rol.This study interprets the theoretical basis of PMI-oriented cancer progression and targeting therapies in clinic.展开更多
目的日本血吸虫可能的多药物抗性基因的发掘和所编码的蛋白的结构、功能以及应用前景分析。方法利用美国国家生物技术信息中心(NCBI,http://www.ncbi.nlm.nih.gov/)的在线分析工具BLASTx和瑞士生物信息学研究所的蛋白分析专家系统(ExPaS...目的日本血吸虫可能的多药物抗性基因的发掘和所编码的蛋白的结构、功能以及应用前景分析。方法利用美国国家生物技术信息中心(NCBI,http://www.ncbi.nlm.nih.gov/)的在线分析工具BLASTx和瑞士生物信息学研究所的蛋白分析专家系统(ExPaSy,http://ca.expasy.org/)和CBS Prediction Servers提供的蛋白序列在线分析工具,结合Vector NTI suite生物信息学分析软件,以华支睾吸虫小蛋白多药物抗性基因(smr)为"饵",从GenBank日本血吸虫基因数据库中发掘出其同源基因,预测蛋白的结构和功能特征,并分析其应用前景。结果从GenBank中找到了一个功能未知的日本血吸虫同源基因AY813157,氨基酸序列与华支睾吸虫smr蛋白的一致性达67%,相似性达80%;该基因含有一个完整的编码区,编码189个氨基酸;预测氨基酸序列具有主要协助因子超家族的结构特征,含有5段跨膜区,其中3段跨膜区中含有保守的精氨酸和组氨酸残基,有多个磷酸化位点和T、B细胞表位。拓扑学分析表明N端在胞内,C端在胞外,线性B细胞表位均位于胞外区。结论日本血吸虫AY813157基因可能编码一个小蛋白型多药物/代谢物排出蛋白,与阴离子型药物(如吡喹酮)的抗药性或有毒性的阴离子代谢物的排出有关;该蛋白可能定位于皮层的表膜,是一个日本血吸虫免疫诊断和疫苗的候选靶分子,在研究日本血吸虫的耐药机制及免疫诊断和疫苗方面较好的应用前景。展开更多
基金supported by the National Natural Science Foundation of China(No.81672440)Innovation Program of Science and Research from the DICP,CAS(No.DICP TMSR201601)the 100 Talents Program of Chinese Academy of Sciences
文摘Active endogenous metabolites regulate the viability of cells. This process is controlled by a series ofinteractions between small metabolites and large proteins. Previously, several studies had reported thatmetabolite regulates the protein functions, such as diacylglycerol to protein kinase C, lactose regulationof the lac repressor, and HIF-1α stabilization by 2-hydroxyglutarate. However, decades old traditionalbiochemical methods are insufficient to systematically investigate the bio-molecular reactions for a high-throughput discovery. Here, we have reviewed an update on the recently developed chemical proteomicscalled activity-based protein profiling （ABPP）. ABPP is able to identify proteins interacted eithercovalently or non-covalently with metabolites significantly. Thus, ABPP will facilitate the characteriza-tion of specific metabolite regulating; proteins in human disease progression.
基金the National Natural Science Foundation of China(Nos.81672440,21575142)Innovation Program of Science and Research from the DICP,CAS(No.DICP ZZBS201803)。
文摘Protein-metabolite interactions(PMIs)play important roles in various biological processes,especially in disease progression.However,due to the complexity of living cells,it is very difficult to identify specific PMIs.Herein,we chose one oncogenic factor,metadherin(MTDH),as a bait to identify its in vivo interacting metabolites in cancer cells.Cholesterol is an important metabolite and essential structural component of cell membranes.It could also drive several diseases including cancer.Interestingly,we found that cholesterol robustly interacted with MTDH and downregulated the expression of MTDH in cancer cells.Furthermore,MTDH disturbed metabolite alterations under cholesterol treatment in MTDH transduced cancer cells.Collectively,our results uncover an undescribed PMI where MTDH,as an oncogenic factor,might positively regulate cancer progression by interacting with choleste rol.This study interprets the theoretical basis of PMI-oriented cancer progression and targeting therapies in clinic.
文摘目的日本血吸虫可能的多药物抗性基因的发掘和所编码的蛋白的结构、功能以及应用前景分析。方法利用美国国家生物技术信息中心(NCBI,http://www.ncbi.nlm.nih.gov/)的在线分析工具BLASTx和瑞士生物信息学研究所的蛋白分析专家系统(ExPaSy,http://ca.expasy.org/)和CBS Prediction Servers提供的蛋白序列在线分析工具,结合Vector NTI suite生物信息学分析软件,以华支睾吸虫小蛋白多药物抗性基因(smr)为"饵",从GenBank日本血吸虫基因数据库中发掘出其同源基因,预测蛋白的结构和功能特征,并分析其应用前景。结果从GenBank中找到了一个功能未知的日本血吸虫同源基因AY813157,氨基酸序列与华支睾吸虫smr蛋白的一致性达67%,相似性达80%;该基因含有一个完整的编码区,编码189个氨基酸;预测氨基酸序列具有主要协助因子超家族的结构特征,含有5段跨膜区,其中3段跨膜区中含有保守的精氨酸和组氨酸残基,有多个磷酸化位点和T、B细胞表位。拓扑学分析表明N端在胞内,C端在胞外,线性B细胞表位均位于胞外区。结论日本血吸虫AY813157基因可能编码一个小蛋白型多药物/代谢物排出蛋白,与阴离子型药物(如吡喹酮)的抗药性或有毒性的阴离子代谢物的排出有关;该蛋白可能定位于皮层的表膜,是一个日本血吸虫免疫诊断和疫苗的候选靶分子,在研究日本血吸虫的耐药机制及免疫诊断和疫苗方面较好的应用前景。
